180 Life Sciences Debt / Equity
Cos'è Debt / Equity di 180 Life Sciences?
Debt / Equity di 180 Life Sciences Corp. è -42.18
Qual è la definizione di Debt / Equity?
Il rapporto debito è un rapporto finanziario che indica la proporzione relativa del patrimonio netto e del debito utilizzato per finanziare le attività di una società.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt / Equity di aziende nel Health Care settore su NASDAQ rispetto a 180 Life Sciences
Cosa fa 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Aziende con debt / equity simili a 180 Life Sciences
- American Eagle Gold ha Debt / Equity di -44.07
- The Home Depot ha Debt / Equity di -43.38
- MPower ha Debt / Equity di -43.19
- GMR Infrastructure ha Debt / Equity di -43.03
- Hampton ha Debt / Equity di -42.84
- MRO-TEK Realty ha Debt / Equity di -42.65
- 180 Life Sciences ha Debt / Equity di -42.18
- Aon plc ha Debt / Equity di -42.01
- Masco ha Debt / Equity di -41.64
- BlueBird Battery Metals ha Debt / Equity di -40.30
- Huntsman Exploration Inc ha Debt / Equity di -40.30
- Huntsman Exploration Inc ha Debt / Equity di -40.30
- Fantasia Co ha Debt / Equity di -39.39